Form 8-K - Current report:
SEC Accession No. 0001558370-21-015873
Filing Date
2021-11-15
Accepted
2021-11-15 08:18:12
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20211115x8k.htm   iXBRL 8-K 40303
2 EX-99.1 nrbo-20211115xex99d1.htm EX-99.1 142871
3 GRAPHIC nrbo-20211115xex99d1001.jpg GRAPHIC 6095
  Complete submission text file 0001558370-21-015873.txt   326802

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20211115.xsd EX-101.SCH 3066
5 EX-101.LAB nrbo-20211115_lab.xml EX-101.LAB 16587
6 EX-101.PRE nrbo-20211115_pre.xml EX-101.PRE 10473
7 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20211115x8k_htm.xml XML 5104
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 211406528
SIC: 2834 Pharmaceutical Preparations